Apollon Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Buy
1,963
+119
+6% +$122K 0.28% 80
2026
Q1
$1.7M Sell
1,844
-188
-9% -$191K 0.23% 98
2025
Q4
$2.18M Buy
2,032
+276
+16% +$264K 0.32% 73
2025
Q3
$1.34M Buy
1,756
+139
+9% +$103K 0.22% 90
2025
Q2
$1.26M Buy
1,617
+3
+0.2% +$2.33K 0.26% 83
2025
Q1
$1.33M Buy
1,614
+37
+2% +$30.8K 0.31% 75
2024
Q4
$1.22M Buy
1,577
+74
+5% +$61.3K 0.3% 76
2024
Q3
$1.33M Buy
1,503
+293
+24% +$263K 0.39% 53
2024
Q2
$1.1M Buy
1,210
+238
+24% +$190K 0.35% 55
2024
Q1
$756K Buy
972
+203
+26% +$144K 0.26% 71
2023
Q4
$448K Buy
+769
New +$449K 0.18% 88

Other funds holding LLY

Apollon Financial's LLY Position: Q2 2026 in Review

Apollon Financial increased its Eli Lilly (LLY) stake by 6.5% in Q2 2026, buying an estimated $122K and bringing the position to 1,963 shares worth $2.35M. The position accounts for 0.28% of the portfolio, ranked #80.

Apollon Financial first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,206 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Apollon Financial held 1,963 shares of Eli Lilly worth $2.35M as of Q2 2026.
  • Apollon Financial bought 119 Eli Lilly shares in Q2 2026, an estimated $122K.
  • Eli Lilly made up 0.28% of Apollon Financial's portfolio in Q2 2026, its #80 holding.
  • Apollon Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,206 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.